Patents Assigned to Sensorium Therapeutics, Inc.
  • Delivery of therapeutic alkaloid compounds
    Patent number: 12269800
    Abstract: Disclosed are prodrug compounds that can be converted to mesembrine under biologically relevant conditions, such as hydrolysis in vivo; and related methods of preparing and using these compounds. Stable preparations of isolated mesembrine stereoisomers are also provided.
    Type: Grant
    Filed: January 5, 2024
    Date of Patent: April 8, 2025
    Assignee: Sensorium Therapeutics, Inc.
    Inventors: Jacob M. Hooker, Michael S. Placzek
  • Delivery of therapeutic alkaloid compounds
    Patent number: 11999694
    Abstract: Disclosed are prodrug compounds that can be converted to mesembrine under biologically relevant conditions, such as hydrolysis in vivo; and related methods of preparing and using these compounds. Stable preparations of isolated mesembrine stereoisomers are also provided.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: June 4, 2024
    Assignee: Sensorium Therapeutics, Inc.
    Inventors: Jacob M. Hooker, Michael S. Placzek